Risk and Relapse Patterns in Triple-Negative Breast Cancer
In a groundbreaking advance for oncology and personalized cancer therapy, the European GAMBIT study unravels critical insights into the risk ...
In a groundbreaking advance for oncology and personalized cancer therapy, the European GAMBIT study unravels critical insights into the risk ...
The landscape of HER2-positive breast cancer treatment continues to evolve rapidly, with researchers tirelessly seeking enhanced neoadjuvant therapies that can ...
A groundbreaking study published in BMC Cancer introduces a revolutionary multi-modal radiomics model designed to predict pathological complete response (pCR) ...
In an era where precision medicine increasingly shapes cancer treatment, the ability to predict therapeutic outcomes with accuracy remains a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine